HC Wainwright & Co. Reiterates Buy on Arcadia Biosciences, Maintains $15 Price Target
Portfolio Pulse from richadhand@benzinga.com
HC Wainwright & Co. analyst Raghuram Selvaraju has reiterated a 'Buy' rating on Arcadia Biosciences (NASDAQ:RKDA) and maintained a $15 price target.
July 24, 2023 | 10:43 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Arcadia Biosciences' stock may see positive movement as HC Wainwright & Co. maintains a 'Buy' rating and a $15 price target.
Analyst ratings and price targets can significantly influence investor sentiment and stock price. The reiteration of a 'Buy' rating and a maintained price target of $15 by HC Wainwright & Co. suggests a positive outlook for Arcadia Biosciences, which could lead to an increase in its stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100